Moderna (MRNA) Inventory (2020 - 2026)

Moderna (MRNA) has 7 years of Inventory data on file, last reported at $146.0 million in Q1 2026.

• On a quarterly basis, Inventory rose 14.06% year-over-year to $146.0 million in Q1 2026; TTM through Mar 2026 was $146.0 million, a 14.06% increase from a year earlier, with the FY2025 full-year figure at $153.0 million, up 30.77% from the prior year.
• Inventory for Q1 2026 stood at $146.0 million, down from $153.0 million in the prior quarter.
• Over the last five years, Inventory for MRNA reached as high as $2.1 billion in Q3 2022 and fell as low as $117.0 million in Q4 2024.
• Historically, Inventory has averaged $661.6 million across 5 years, with a median of $399.0 million in 2024.
• Across the five-year window, Inventory surged 293.12% in 2022 and slumped 78.71% in 2023, its largest moves.
• Year by year, Inventory stood at $949.0 million in 2022, then sank by 78.71% to $202.0 million in 2023, then slumped by 42.08% to $117.0 million in 2024, then surged by 30.77% to $153.0 million in 2025, then dropped by 4.58% to $146.0 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $146.0 million in Q1 2026, $153.0 million in Q4 2025, and $332.0 million in Q3 2025.